中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
22期
9945-9948
,共4页
沈洪亮%杨培谦%田野%徐岩%吴晓华%贺文
瀋洪亮%楊培謙%田野%徐巖%吳曉華%賀文
침홍량%양배겸%전야%서암%오효화%하문
癌,肾细胞%诊断,鉴别%体层摄影术,X线计算机
癌,腎細胞%診斷,鑒彆%體層攝影術,X線計算機
암,신세포%진단,감별%체층섭영술,X선계산궤
Carcinoma,renal cell%Diagnosis,differential%Tomography,X-ray computed
目的:探讨校正 CT 值在 CT 诊断肾癌中的应用价值。方法对我院近期83例肾癌患者的CT资料进行回顾性分析。所有患者均实施手术治疗,病理诊断透明细胞癌69例、乳头状细胞癌14例。分析内容包括测量CT扫描各期肿瘤最大截面直径、肿瘤的平均CT值(TNC、TCP和TPP代表肿瘤平扫期、皮质期和实质期的CT值)、主动脉CT值(ANC、ACP、APP代表主动脉平扫期、皮质期和实质期的CT值)和正常肾实质CT值(KNC、KCP、KPP代表肾实质平扫期、皮质期和实质期的CT值)。计算4个校正CT值(R 代表):R1=(TCP-TNC)/(ACP-ANC),R2=(TPP-TNC)/(APP-ANC),R3=(TCP-TNC)/(KCP-KNC),R4=(TPP-TNC)/(KPP-KNC)。对透明细胞癌组和乳头状细胞癌组的各种CT检查参数进行比较,应用受试者工作特征曲线(receiver operating characteristic,ROC)分析各种检查参数的诊断效能。结果两组的TNC无统计学差异(P=0.261),但透明细胞癌组的TCP、TPP和校正CT值均显著高于乳头状细胞癌组(均P<0.05)。ROC曲线下面积值(area under the ROC curve,AUC),R1的AUC最高,其次为TCP。结论校正CT值不仅消除了患者内在因素对肿瘤增强的影响,而且与TCP、TPP联合应用时有助于肾癌亚型的鉴别。
目的:探討校正 CT 值在 CT 診斷腎癌中的應用價值。方法對我院近期83例腎癌患者的CT資料進行迴顧性分析。所有患者均實施手術治療,病理診斷透明細胞癌69例、乳頭狀細胞癌14例。分析內容包括測量CT掃描各期腫瘤最大截麵直徑、腫瘤的平均CT值(TNC、TCP和TPP代錶腫瘤平掃期、皮質期和實質期的CT值)、主動脈CT值(ANC、ACP、APP代錶主動脈平掃期、皮質期和實質期的CT值)和正常腎實質CT值(KNC、KCP、KPP代錶腎實質平掃期、皮質期和實質期的CT值)。計算4箇校正CT值(R 代錶):R1=(TCP-TNC)/(ACP-ANC),R2=(TPP-TNC)/(APP-ANC),R3=(TCP-TNC)/(KCP-KNC),R4=(TPP-TNC)/(KPP-KNC)。對透明細胞癌組和乳頭狀細胞癌組的各種CT檢查參數進行比較,應用受試者工作特徵麯線(receiver operating characteristic,ROC)分析各種檢查參數的診斷效能。結果兩組的TNC無統計學差異(P=0.261),但透明細胞癌組的TCP、TPP和校正CT值均顯著高于乳頭狀細胞癌組(均P<0.05)。ROC麯線下麵積值(area under the ROC curve,AUC),R1的AUC最高,其次為TCP。結論校正CT值不僅消除瞭患者內在因素對腫瘤增彊的影響,而且與TCP、TPP聯閤應用時有助于腎癌亞型的鑒彆。
목적:탐토교정 CT 치재 CT 진단신암중적응용개치。방법대아원근기83례신암환자적CT자료진행회고성분석。소유환자균실시수술치료,병리진단투명세포암69례、유두상세포암14례。분석내용포괄측량CT소묘각기종류최대절면직경、종류적평균CT치(TNC、TCP화TPP대표종류평소기、피질기화실질기적CT치)、주동맥CT치(ANC、ACP、APP대표주동맥평소기、피질기화실질기적CT치)화정상신실질CT치(KNC、KCP、KPP대표신실질평소기、피질기화실질기적CT치)。계산4개교정CT치(R 대표):R1=(TCP-TNC)/(ACP-ANC),R2=(TPP-TNC)/(APP-ANC),R3=(TCP-TNC)/(KCP-KNC),R4=(TPP-TNC)/(KPP-KNC)。대투명세포암조화유두상세포암조적각충CT검사삼수진행비교,응용수시자공작특정곡선(receiver operating characteristic,ROC)분석각충검사삼수적진단효능。결과량조적TNC무통계학차이(P=0.261),단투명세포암조적TCP、TPP화교정CT치균현저고우유두상세포암조(균P<0.05)。ROC곡선하면적치(area under the ROC curve,AUC),R1적AUC최고,기차위TCP。결론교정CT치불부소제료환자내재인소대종류증강적영향,이차여TCP、TPP연합응용시유조우신암아형적감별。
Objective To investigate the corrected CT value in the diagnosis of renal cell carcinoma. Methods Retrospective analysis was conducted on the 83 CT data of renal cell carcinoma operated in our hospital.. Clear cell carcinomas diagnosed by pathology were 69 cases, and papillary cell carcinomas were 14 cases. The analysis included average maximum tumor diameter, CT values of the tumor, the aorta and the renal parenchyma in different phases of CT scanning. TNC, TCP and TPP represented CT values in the unenhanced, vascular and parenchyma phase respectively;ANC, ACP and APP represented CT values of aorta in the unenhanced, vascular and parenchyma phase respectively;KNC, KCP and KPP represented CT values of normal renal parenchyma in the unenhanced, vascular and parenchyma phase respectively. The four corrected CT values(R represented a corrected CT value)were calculated: R1=(TCP-TNC) / (ACP-ANC), R2=(TPP-TNC)/(APP-ANC), R3=(TCP-TNC) /(KCP-KNC), R4=(TPP-TNC)/(KPP-KNC). These parameters of CT were compared between the clear cell carcinomas and papillary cell carcinomas. The receiver operating characteristic(ROC)were used to assess diagnostic efficiency of various parameters. Results There was no significant difference between the TNC of renal clear cell carcinoma and TNC of papillary carcinoma cells (P>0.05). But, the TCP, TPP and the four corrected CT values of clear cell carcinoma were significantly higher than those of papillary renal cell carcinoma (P<0.05). According to area under the ROC curve (AUC), the AUC of R1 was the biggest, followed by TCP. Conclusion The corrected CT values in the diagnosis of renal cell carcinoma can not only eliminate the intrinsic factors of patients with the effect on the degree of tumor enhancement, but also contribute to distinguishing the subtype of renal cell carcinoma when they were combination with TCP and TPP.